07/31/2025
5:52 AM | Apellis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/17/2025
3:56 PM | Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2025
3:10 PM | Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2025
3:11 PM | Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/14/2025
3:50 PM | Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2025
6:09 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2025
7:49 AM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
9:38 AM | Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2025
3:10 PM | Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
3:15 PM | Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
3:05 PM | Apellis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for APLS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Apellis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
05/29/2025
10:46 AM | Apellis Pharmaceuticals (Issuer)
Boucher Kelley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2025
10:44 AM | Apellis Pharmaceuticals (Issuer)
Boucher Kelley (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/22/2025
12:19 PM | Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2025
3:42 PM | Apellis Pharmaceuticals (Subject)
Deep Track Capital, LP (Filed by)
| Form SCHEDULE 13G | |
05/12/2025
1:22 PM | Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2025
6:01 AM | Apellis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/23/2025
6:33 AM | Apellis Pharmaceuticals (Filer)
| Form DEF 14A | |
04/23/2025
6:35 AM | Apellis Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2025
6:36 AM | Apellis Pharmaceuticals (Filer)
| Form ARS | |
04/21/2025
3:23 PM | Apellis Pharmaceuticals (Issuer)
WHEELER CRAIG A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
6:11 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
11:27 AM | Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
2:18 PM | Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
6:22 AM | Apellis Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2025
6:00 AM | Apellis Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2025
12:59 PM | Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
2:13 PM | Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/10/2025
9:49 AM | Apellis Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
02/03/2025
12:09 PM | Apellis Pharmaceuticals (Subject)
MORGAN STANLEY (Filed by)
| Form SCHEDULE 13G | |
01/30/2025
11:13 AM | Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
11:15 AM | Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
11:18 AM | Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
11:20 AM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
11:01 AM | Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
11:03 AM | Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
11:07 AM | Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
11:10 AM | Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
11:12 AM | Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
2:42 PM | Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
2:18 PM | Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Why AMZN, GOOG, MSFT might destroy NVDA (Ad) Investing Legend Hints the End May be Near for These 3 Iconic Stocks
Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast. Click to get the full details on Eric Fry's "Nvidia alternative" right here. |
01/29/2025
2:22 PM | Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
2:26 PM | Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
2:11 PM | Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
2:12 PM | Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
2:16 PM | Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
2:16 PM | Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
2:17 PM | Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2025
2:37 PM | Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:39 PM | Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:41 PM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:23 PM | Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:25 PM | Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:26 PM | Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:28 PM | Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:29 PM | Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:31 PM | Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:19 PM | Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
3:00 PM | Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:39 PM | Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:42 PM | Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:43 PM | Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:44 PM | Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:45 PM | Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:45 PM | Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:51 PM | Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:52 PM | Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:56 PM | Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/21/2025
2:56 PM | Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
2:59 PM | Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
2:54 PM | Apellis Pharmaceuticals (Issuer)
Baumal Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
3:38 PM | Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
3:20 PM | Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
3:27 PM | Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
3:29 PM | Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/14/2025
3:22 PM | Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:25 PM | Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:29 PM | Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:30 PM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:09 PM | Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:10 PM | Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:14 PM | Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:15 PM | Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:55 PM | Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
4:56 PM | Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:00 PM | Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:02 PM | Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:02 PM | Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:05 PM | Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:07 PM | Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:09 PM | Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
BREAKING: The House just passed 3 pro-crypto bills! (Ad) THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.  Discover the under-the-radar project I believe will skyrocket as a result. |
01/13/2025
5:13 PM | Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:15 PM | Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
8:08 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
4:38 PM | Apellis Pharmaceuticals (Issuer)
Walbert Keli (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/10/2025
4:39 PM | Apellis Pharmaceuticals (Issuer)
Walbert Keli (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
3:03 PM | Apellis Pharmaceuticals (Issuer)
Baumal Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
2:17 PM | Apellis Pharmaceuticals (Subject)
Baumal Caroline (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2024
3:06 PM | Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
3:15 PM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free APLS Stock Alerts